Published date: 23 November 2020

This notice was replaced on 23 November 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 23 November 2020, last edited 25 November 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£35,000,000

Procurement reference

CF-0068600D0O000000rwimUAA1

Published date

23 November 2020

Closing date

8 December 2020

Closing time

12am

Contract start date

21 December 2020

Contract end date

31 October 2021

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

This is an accelerated procedure.

Justification

This requirement to call for competition came about due to the availability of competitive supply in circumstances relating to intellectual property rights that could not have been foreseen and/or acted upon by the authority using regular tender timescales.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

About the buyer

Contact name

Gemma Tomlinson

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
GB

Email

gemma.tomlinson1@nhs.net